Afatinib Dimaleate 20 mg (Generic)

Active IngredientAfatinib Dimaleate
Indication:Non-small cell lung cancer
Manufacturer:Boehringer Ingelheim India Pvt.Ltd
Packaging:7 tablets in 1 strip
Strength:20mg
Delivery Time:6 To 15 days
Afatinib Dimaleate 20 mg is a targeted oral therapy for non-small cell lung cancer that blocks EGFR mutations, helping to control tumor growth effectively. Developed by Boehringer Ingelheim India Pvt.Ltd, it offers a focused approach to advanced lung cancer treatment.
Share:

Afatinib Dimaleate 20 mg (Generic)

20mgPricePrice/unitQtyCart
28 Tablet/s $900.00 $32.14 / Tablet
56 Tablet/s $1,700.00 $30.36 / Tablet
84 Tablet/s $2,300.00 $27.38 / Tablet